The pharma industry registered a 7.5% value growth year-on-year for the month of February, with sales of ₹18,781 crore, ...

Pharmaceutical majors AstraZeneca and GSK have partnered with competitor Takeda and nine suppliers to accelerate the adoption ...

India’s pharmaceutical exports to the US stand at ... a global consulting firm. The report revealed that Indian pharmaceuticals saved the US healthcare system $219 billion in 2022 alone, with total ...

India supplies over 60% of the world’s vaccines and 70% of global antiretroviral drugs for HIV treatment, reports Financial Express.

Rajesh Dogra, chief customer experience officer at Air India at the ET CX Annual Symposium 2025 In a fireside chat at ET CX Annual Symposium 2025, Rajesh Dogra, chief customer experience officer ...

If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not ...

SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will participate in a fireside chat at TD Cowen’s 45th Annual Health Care Conference on Wednesday, March ...

Patients in Ireland could access new medicines up to a year earlier, according to a new position paper published yesterday by the Irish Pharmaceutical ... at the IPHA annual conference ...

LONDON - GSK plc, the global healthcare company, has released its Annual Report for the fiscal year ending December 31, 2024. The report was published on the company's website today and is also set to ...

In Q4, subscription revenue fell 10.7% to $20.68 million. Q4 Pharma manufacturer solutions revenue jumped from $24.4 million to $28.1 million. 2024 Pharma manufacturer solutions revenue increased ...

The initiatives to improve healthcare access — including Ayushman Bharat, which provides financial protection and better ...

The Company has today published on its website www.annualreport.gsk.com its Annual Report for the year ended 31 December 2024 ('Annual Report 2024'). In compliance with Listing Rule 6.4.1R of the ...